QGEN
$48.04
Qiagen N.V.
($.32)
(.66%)
QGEN
Earnings Whisper ®
N/A
3rd Quarter September 2025
Consensus:  $0.59
Revenue:  $522.77 Mil
Tuesday
Nov 4
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Guidance announcement made Tuesday, August 5, 2025

What do you expect when QGEN reports earnings?
Beat
Meet
Miss

Where is QGEN's stock price going from here?
Up
Flat
Down
Stock chart of QGEN
Analysts
Summary of analysts' recommendations for QGEN
Score
Grade
Pivots
Resistance
$48.76
$48.45
$48.25

$47.94

Support
$47.73
$47.42
$47.22
Tweet
Growth
Description
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Peers
BiogenAmgenGilead SciencesNeurocrine BiosciencesRepligenBio-TechneBioCryst PharmaceuticalsStemNovavaxSangamo Therapeutics